Reconocer estas seales de alerta es fundamental para prevenir complicaciones y optimizar los resultados teraputicos
The intra-subject and inter-subject coefficients of variation for sitagliptin AUC were small (5.8% and 15.1%)
botanical origin not reported) as an adjunct to risperidone in children with ASD
[6] Preclinical studies in animal models suggest that GLP-1 receptor activation may: Promote neuroplasticity and neurogenesis (formation of new neurons) in the hippocampus, a region often showing reduced volume in depression Modulate neurotransmitter systems , particularly dopamine and serotonin pathways involved in mood regulation and reward processing Reduce neuroinflammation , which is increasingly recognised as contributing to depressive disorders Enhance brain-derived neurotrophic factor (BDNF) expression, a protein crucial for neuronal health and resilience Metabolic improvements associated with GLP-1 therapy may also contribute indirectly to mood benefits
Glutathione can inhibit the activity of enzyme tyrosinase, which is linked to melanin production
Las incretinas endgenas, como el GLP-1 (pptido similar al glucagn 1) y el GIP (pptido insulinotrpico dependiente de glucosa), se producen en las clulas intestinales L y K, respectivamente
